Global Quinine Dihydrochloride Injection Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
Description
According to our (Global Info Research) latest study, the global Quinine Dihydrochloride Injection market size was valued at US$ 207 million in 2024 and is forecast to a readjusted size of USD 309 million by 2031 with a CAGR of 6.0% during review period.
Quinine dihydrochloride is an antimalarial medication that has been used for many years to treat malaria, a mosquito-borne infectious disease caused by Plasmodium parasites. One of the key market trends in the global quinine dihydrochloride injection market could be a resurgence in its use for malaria treatment due to various factors:
Malaria Incidence and Drug Resistance: Malaria remains a significant public health challenge in many regions, especially in sub-Saharan Africa and parts of Southeast Asia. The emergence of drug-resistant strains of malaria parasites has limited the efficacy of some antimalarial drugs, leading to a renewed interest in quinine dihydrochloride as a treatment option.
Low-Cost Alternative: Quinine dihydrochloride is a relatively low-cost antimalarial medication, making it an attractive option for regions with limited healthcare resources and budget constraints.
World Health Organization (WHO) Guidelines: The World Health Organization periodically updates its guidelines for the treatment of malaria. Depending on the prevalence of drug-resistant malaria in certain regions, quinine dihydrochloride might be recommended as a first-line or alternative treatment.
This report is a detailed and comprehensive analysis for global Quinine Dihydrochloride Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Quinine Dihydrochloride Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Quinine Dihydrochloride Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Quinine Dihydrochloride Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Quinine Dihydrochloride Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Quinine Dihydrochloride Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Quinine Dihydrochloride Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Krosyl Pharmaceuticals, Phebra, Pemason Pharmaceuticals, Lavina Pharma, Venus Pharma, AdvaCare Pharma, Pharmakina, Zhangfeng Zhiyao, Straits Pharmaceutical, Kunming Yusi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Quinine Dihydrochloride Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
250mg/ml
500mg/ml
Others
Market segment by Application
Malaria
Nocturnal Muscle Cramps
Varicose
Major players covered
Krosyl Pharmaceuticals
Phebra
Pemason Pharmaceuticals
Lavina Pharma
Venus Pharma
AdvaCare Pharma
Pharmakina
Zhangfeng Zhiyao
Straits Pharmaceutical
Kunming Yusi
Yunnan Phyto Pharmaceutical
Kpc Pharmaceuticals
Grand Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quinine Dihydrochloride Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quinine Dihydrochloride Injection, with price, sales quantity, revenue, and global market share of Quinine Dihydrochloride Injection from 2020 to 2025.
Chapter 3, the Quinine Dihydrochloride Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quinine Dihydrochloride Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Quinine Dihydrochloride Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quinine Dihydrochloride Injection.
Chapter 14 and 15, to describe Quinine Dihydrochloride Injection sales channel, distributors, customers, research findings and conclusion.
Quinine dihydrochloride is an antimalarial medication that has been used for many years to treat malaria, a mosquito-borne infectious disease caused by Plasmodium parasites. One of the key market trends in the global quinine dihydrochloride injection market could be a resurgence in its use for malaria treatment due to various factors:
Malaria Incidence and Drug Resistance: Malaria remains a significant public health challenge in many regions, especially in sub-Saharan Africa and parts of Southeast Asia. The emergence of drug-resistant strains of malaria parasites has limited the efficacy of some antimalarial drugs, leading to a renewed interest in quinine dihydrochloride as a treatment option.
Low-Cost Alternative: Quinine dihydrochloride is a relatively low-cost antimalarial medication, making it an attractive option for regions with limited healthcare resources and budget constraints.
World Health Organization (WHO) Guidelines: The World Health Organization periodically updates its guidelines for the treatment of malaria. Depending on the prevalence of drug-resistant malaria in certain regions, quinine dihydrochloride might be recommended as a first-line or alternative treatment.
This report is a detailed and comprehensive analysis for global Quinine Dihydrochloride Injection market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Quinine Dihydrochloride Injection market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Quinine Dihydrochloride Injection market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Quinine Dihydrochloride Injection market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Quinine Dihydrochloride Injection market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Quinine Dihydrochloride Injection
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Quinine Dihydrochloride Injection market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Krosyl Pharmaceuticals, Phebra, Pemason Pharmaceuticals, Lavina Pharma, Venus Pharma, AdvaCare Pharma, Pharmakina, Zhangfeng Zhiyao, Straits Pharmaceutical, Kunming Yusi, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Quinine Dihydrochloride Injection market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
250mg/ml
500mg/ml
Others
Market segment by Application
Malaria
Nocturnal Muscle Cramps
Varicose
Major players covered
Krosyl Pharmaceuticals
Phebra
Pemason Pharmaceuticals
Lavina Pharma
Venus Pharma
AdvaCare Pharma
Pharmakina
Zhangfeng Zhiyao
Straits Pharmaceutical
Kunming Yusi
Yunnan Phyto Pharmaceutical
Kpc Pharmaceuticals
Grand Pharma
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Quinine Dihydrochloride Injection product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Quinine Dihydrochloride Injection, with price, sales quantity, revenue, and global market share of Quinine Dihydrochloride Injection from 2020 to 2025.
Chapter 3, the Quinine Dihydrochloride Injection competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Quinine Dihydrochloride Injection breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Quinine Dihydrochloride Injection market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Quinine Dihydrochloride Injection.
Chapter 14 and 15, to describe Quinine Dihydrochloride Injection sales channel, distributors, customers, research findings and conclusion.
Table of Contents
122 Pages
- 1 Market Overview
- 2 Manufacturers Profiles
- 3 Competitive Environment: Quinine Dihydrochloride Injection by Manufacturer
- 4 Consumption Analysis by Region
- 5 Market Segment by Type
- 6 Market Segment by Application
- 7 North America
- 8 Europe
- 9 Asia-Pacific
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
